Publications by authors named "Rozan Al-Far"
Introduction: Poor graft function (PrGF) is a serious complication of allogeneic hematopoietic cell transplantation (allo-HCT), and current therapies are only partially effective. Eight published reports on the effect of eltrombopag on PrGF showed encouraging results. This study aimed to assess the safety and efficacy of eltrombopag for the treatment of PrGF after allo-HCT.
View Article and Find Full Text PDFArticle Synopsis
- * A study reviewed 166 patient records, focusing on 143 without prior central nervous system (CNS) involvement, and analyzed the outcomes of those who received TBI with or without CRB.
- * Results showed no significant differences in relapse rates or survival between patients with and without CRB, indicating that adding CRB may not provide extra benefits in preventing relapses after transplantation.